Published in Proc Natl Acad Sci U S A on March 01, 1973
Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci U S A (1978) 3.05
Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions. J Exp Med (1976) 2.24
Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through identification of its human homologue as the fourth component of complement. Proc Natl Acad Sci U S A (1975) 2.07
Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40
Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system. J Exp Med (1975) 1.34
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Genetic linkage between serum levels of the third component of complement and the H-2 complex. J Exp Med (1975) 1.20
Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease. J Clin Invest (1977) 1.18
Mapping of the immune response genes in the major histocompatibility complex of the Rhesus monkey. J Exp Med (1975) 1.02
Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement. Proc Natl Acad Sci U S A (1978) 1.01
Studies on murine Ss protein: demonstration that S region encodes structural gene for fourth component of complement. Proc Natl Acad Sci U S A (1979) 1.00
The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement. J Clin Invest (1976) 1.00
A murine C4 molecule with reduced hemolytic efficiency. J Exp Med (1980) 0.97
The major histocompatibility complex--comparison in the mouse, man, and the rat. A review. Am J Pathol (1978) 0.87
Ontogeny of B lymphocytes. 3. H-2 linkage of a gene controlling the rate of appearance of complement receptor lymphocytes. J Exp Med (1974) 0.87
The role of complement in the induction and regulation of immune responses. Immunology (1984) 0.84
Studies on the murine Ss protein. I. Purification, molecular weight, and subunit structure. J Exp Med (1975) 0.83
Mouse chromosome 17. Mamm Genome (1992) 0.78
Genetics of the complement system. J Med Genet (1975) 0.77
Mouse chromosome 17. Mamm Genome (1991) 0.77
Association of serum hemolytic complement levels with the major histocompatibility complex in chickens. J Exp Med (1976) 0.75
Influence of mouse genotype on passive systemic anaphylaxis by immune complexes. Infect Immun (1986) 0.75
Activity of mouse complement. J Immunol (1962) 5.14
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
A gene locus concerned with hemolytic complement in Mus musculus. Genetics (1963) 3.58
Genetic control of the antibody response in inbred mice. Transfer of response by spleen cells and linkage to the major histocompatibility (H-2) locus. J Exp Med (1968) 3.52
The H-2 locus of the mouse: observations and speculations concerning its comparative genetics and its polymorphism. Folia Biol (Praha) (1968) 3.43
A sex-limited serum protein variant in the mouse: inheritance and association with the H-2 region. Biochem Genet (1970) 2.24
A Serologically Detected Variant in Mouse Serum: Inheritance and Association with the Histocompatibility-2 Locus. Genetics (1963) 1.86
Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse. J Exp Med (1972) 1.70
Genetic control of haemolytic complement in mice: association with H-2. Folia Biol (Praha) (1972) 1.41
The major histocompatibility antigens in various species. Curr Top Microbiol Immunol (1970) 1.00
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics (1986) 2.28
Hemagglutination and cytotoxic studies of H-2. I. H-2.1 and related specificities in the EK crossover regions. Transplantation (1971) 1.69
A molecular basis for the two locus model of human complement component C4. Nature (1982) 1.65
A new H-2-linked mutation, rds, causing retinal degeneration in the mouse. Tissue Antigens (1978) 1.54
Genetic control of haemolytic complement in mice: association with H-2. Folia Biol (Praha) (1972) 1.41
Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A. Transplant Proc (1971) 1.41
H-2 gene complex and its role in alloimmune reactions. Transplant Rev (1973) 1.36
Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength. Transplant Proc (1973) 1.26
The effects of a t-allele (tAE5) in the mouse on the lymphoid system and reproduction. J Embryol Exp Morphol (1976) 1.22
Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum Immunol (2008) 1.10
Genetic studies of the H-2-associated complement gene. Folia Biol (Praha) (1974) 1.04
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc Natl Acad Sci U S A (1992) 0.97
Mixed lymphocyte reaction caused by an H-2D mutation (congenic strains-B10.D2 new-B10.504). Folia Biol (Praha) (1972) 0.94
Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes. Immunogenetics (1984) 0.94
H-2-dependent regulation of the high level of expression of ecotropic murine leukemia virus. J Natl Cancer Inst (1979) 0.94
The map position of the rds gene on the 17th chromosome of the mouse. Tissue Antigens (1979) 0.94
Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum Immunol (2000) 0.94
Molecular heterogeneity of H-2 antigens. Immunol Rev (1981) 0.92
Histocompatibility gene organization and mixed lymphocyte reaction. Nat New Biol (1971) 0.92
T(16: 17)43H translocation as a tool in analysis of the proximal part of chromosome 17 (including T-t gene complex) of the mouse. Genet Res (1980) 0.91
Haemagglutination and cytotoxic studies of H-2. V. T-e anti-27, 28, 29 family of antibodies. Folia Biol (Praha) (1974) 0.91
Further molecular complexities of H-2 K- and D-region antigens. Nature (1981) 0.90
Ss protein: search for cross-reacting substances in different species. Folia Biol (Praha) (1971) 0.89
Hemagglutination and cytotoxic studies of H-2. 3. A family of 3-like specificities not in the C crossover region. Transplantation (1971) 0.89
Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse. Transplant Proc (1973) 0.88
Influence of M-locus (non-H-2) and K-end and D-end (H-2-region) incompatibility on heart muscle allograft survival time. Transplant Proc (1973) 0.88
Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. II. B10.D2(M504) (H-2dm1) mutant fails to express one of the two H-2.4-, 28 + Dd region molecules. Immunogenetics (1982) 0.87
Sub-milliMorgan map of the proximal part of mouse Chromosome 17 including the hybrid sterility 1 gene. Mamm Genome (1996) 0.86
Murine complement factor B (BF): sexual dimorphism and H-2-linked polymorphism. Immunogenetics (1982) 0.86
H-2.28, an alloantigenic marker allelic to H-2.1, is expressed on all three known types of H-2 molecules. Proc Natl Acad Sci U S A (1978) 0.85
A new determinant, Qa-m208, detected on T lymphocytes and transfected L cells by a Kb-specific monoclonal antibody. Immunogenetics (1984) 0.84
[Use of human sperm protein monoclonal antibodies in the diagnosis of sperm pathology and selection of a suitable assisted reproduction method for fertilization]. Ceska Gynekol (2000) 0.83
One (H-2D2b) of the three Db region-controlled molecules (H-2D1b, H-2D2b, H-2Lb) is not detected in bm13 mutant. J Immunol (1983) 0.83
Genetic determinants for the graft-vs.-host reaction in the H-2 complex. Transplant Proc (1973) 0.82
The private specificity H-2.4 and the public specificity H-2.28 of the D region are expressed on two independent polypeptide chains. Eur J Immunol (1977) 0.82
Transplantation analysis of the H-2 system. Transplant Proc (1973) 0.82
Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. III. Reactivity of certain anti-H-2.28 alloantisera with Qa-2 antigen. Immunogenetics (1982) 0.81
Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. I. A. molecule similar to Qa-2, detected in the BALB/cBy but not in the BALB/c-H-2dm2 mutant. Immunogenetics (1982) 0.81
H-2L: demonstration of four new allelic products and independence of H-2D and H-2L molecules. Tissue Antigens (1979) 0.81
Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression. Folia Biol (Praha) (1971) 0.80
H-2 class I antigen expression on mouse teratocarcinoma cell lines. Immunogenetics (1985) 0.80
Two new H-2 specificities: H-2.44 and H-2.45. Folia Biol (Praha) (1972) 0.80
Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes. Immunogenetics (1987) 0.79
Preparation and characterization of a monoclonal antibody against boar acrosin. Folia Biol (Praha) (1986) 0.79
Genetic factors in the ninth linkage group influencing reproductive performance in male mice. Folia Biol (Praha) (1969) 0.79
Qualitative and quantitative aspects of anti-H-2Ld sera. Transplantation (1981) 0.79
Revised rules for naming class I and class II antigenic determinants controlled by the mouse H-2 complex. Immunogenetics (1983) 0.79
Inhibition of adhesion of F9 embryonal carcinoma cells to substratum by a novel monoclonal antibody, TEC-05, reactive with a developmentally regulated carbohydrate epitope. Differentiation (1988) 0.78
Independence of H-2 and viral antigens on the cell surface and absence of H-2 antigens on murine leukemia virus and mouse mammary tumor virus particles. Immunogenetics (1981) 0.78
Prolonged survival of maternal skin grafts in newborn rabbits. Folia Biol (Praha) (1965) 0.78
Cross-reactions between the major histocompatibility system of man and mice (HL-A and H-2). Cytotoxic action of anti-H-2 sera on lymphocytes. Tissue Antigens (1975) 0.78
Subdivision of the S region of the mouse major histocompatibility complex by identification of genomic polymorphisms of the class III genes. Immunogenetics (1984) 0.78
H-2: its structure and similarity to HL-A. Transplant Rev (1973) 0.78
Recessive lethal t haplotypes increase the frequency of the partial trisomy of chromosome 17 (including the T-t complex) among offspring of T(16;17)43H female mice. Folia Biol (Praha) (1986) 0.78
Serological characterization of previously unknown H-2 molecules identified in the products of the Kd and Dk region. Immunogenetics (1981) 0.77
Joint report of first histocompatibility workshop on primates. Transplant Proc (1972) 0.77
Genetic requirements for graft-versus-host reaction in mouse. Different efficacy of incompatibility at D- and K-ends of the H-2 locus. Folia Biol (Praha) (1970) 0.77
The predominant role of the K-end of the H-2 locus in lymphocyte transformation in mixed cultures. Folia Biol (Praha) (1970) 0.77
Five serologically distinguishable Dq region molecules. Immunogenetics (1984) 0.77
HLA--Dw3 in Sjögren's syndrome. Tissue Antigens (1977) 0.77
Strong association of HLA-B27 heavy chain with beta 2-microglobulin. Hum Immunol (2000) 0.76
Monoclonal antibodies to canine intra-acrosomal sperm proteins recognizing acrosomal status during capacitation and acrosome reaction. Andrologia (1997) 0.76
Corticosteroid-induced cleft palate: cis interaction of MHC genes and hybrid resistance. Immunogenetics (1985) 0.76
The mixed lymphocyte reaction in H-2K, H-2D, and non-H-2 incompatibility. Biomedicine (1973) 0.76
Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines. Folia Biol (Praha) (2000) 0.76
Functional heterogeneity of H-2Dk-region products. Immunogenetics (1981) 0.75
Growth inhibitory effect of mouse interferon in transformed cells. Acta Microbiol Acad Sci Hung (1981) 0.75
Interferon-induced changes in the expression and topography of H-2 antigens and receptors for SRBC in tumour cells. Folia Biol (Praha) (1982) 0.75
The distribution of HLA-d (MLC) locus determinants in the Czech population. Folia Biol (Praha) (1977) 0.75
An attempted analysis of interstrain differences in the lymphoid system: strains B10, B10.A and A [proceedings]. Folia Biol (Praha) (1976) 0.75
H-2 antigenic specificities controlled by the translocation chromosome T190. Transplantation (1980) 0.75
[Intraspecies identification of cultured murine cells by using H-2 antigen typing]. Tsitologiia (1988) 0.75
[Determination of HLA-D antigens of the locus in mixed lymphocyte culture and their significance for the clinic (author's transl)]. Cas Lek Cesk (1977) 0.75
Complement dependence of blocking of C3d lymphocyte receptors by anti-H-2 antibodies. Immunobiology (1980) 0.75
[Testing of the hormonal activity of testosterone conjugate with protein]. Cesk Fysiol (1974) 0.75
[The stress of general anaesthesia and surgery in patients in the 8th and 9th decade]. Cesk Stomatol (1983) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
Supertypic HLA-Bw4 antigen detected by a new monoclonal antibody. Exp Clin Immunogenet (1986) 0.75
Biological effects of antitestosterone antibodies: relationship between intensity of immunization, antibody titre, and the state of androgen-dependent traits. Folia Biol (Praha) (1977) 0.75
Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies. Transplant Proc (1981) 0.75
Synergic action of HL-A antibodies. Folia Biol (Praha) (1969) 0.75
Histocompatibility antigens in rabbits and their significance for the survival of maternal skin grafts in newborn rabbits. Folia Biol (Praha) (1968) 0.75
[Surgery of the maxillofacial area in patients in their 80's and 90's]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1981) 0.75
Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice. Folia Biol (Praha) (1983) 0.75
[Cryopreservation of embryos after intracytoplasmic sperm injection (ICSI)]. Ceska Gynekol (1998) 0.75
[Preventive administration of antibiotics in complicated extractions of the lower 3d molars]. Prakt Zubn Lek (1986) 0.75
[Recombinant haplotype H-2 in mice of the congenic resistant strain B10.D1(R108)/Y]. Genetika (1984) 0.75
Opposite effects of the synthetic immunomodulator, muramyl dipeptide, on rejection of mouse skin allografts. Eur J Immunol (1983) 0.75
Genetic complexity of H-2 antigens. Transplant Proc (1981) 0.75
Specificity of cytotoxic antibodies in typing sera against cattle blood group antigens. Folia Biol (Praha) (1967) 0.75
A new H-2 congenic strain B10.ABQ/Ph carrying a recombinant H-2 haplotype derived from balanced lethal stock Ttf/t12. Folia Biol (Praha) (1986) 0.75
Genetic conditions for the release of a lymphokine "lymph node activating factor". Folia Biol (Praha) (1981) 0.75
Computer simulation of the outcome of random immunization in complex immunogenetic systems. I. Independent antigens. Folia Biol (Praha) (1967) 0.75
HLA-D antigens in a Czech population and their association with HLA-DR antigens. Folia Biol (Praha) (1980) 0.75
A contribution to the reproducibility of the mixed lymphocyte culture test and an estimate of low grade values in unselected pairs. Folia Biol (Praha) (1967) 0.75